Pages that link to "Q52784952"
Jump to navigation
Jump to search
The following pages link to A pharmacodynamic model for pancuronium (Q52784952):
Displaying 50 items.
- Volume of the effect compartment in simulations of neuromuscular block (Q24815746) (← links)
- Simultaneous fitting of R- and S-ibuprofen plasma concentrations after oral administration of the racemate (Q28362547) (← links)
- Semiparametric analysis of non-steady-state pharmacodynamic data (Q31141157) (← links)
- Titration of the plasma effect site equilibrium rate constant of propofol; a link method of 'Concentration-Probability-Time'. (Q33861450) (← links)
- Pharmacokinetic studies of neuromuscular blocking agents: good clinical research practice (GCRP). (Q34077383) (← links)
- Understanding the dose-effect relationship: clinical application of pharmacokinetic-pharmacodynamic models (Q34276559) (← links)
- Morphine-6-glucuronide: an analgesic of the future? (Q34340172) (← links)
- Pharmacokinetic Optimisation of Opioid Treatment in Acute Pain Therapy (Q34743090) (← links)
- Population pharmacokinetic–pharmacodynamic analysis for sugammadex‐mediated reversal of rocuronium‐induced neuromuscular blockade (Q35219646) (← links)
- Expanding clinical applications of population pharmacodynamic modelling (Q35803310) (← links)
- Pharmacokinetic and pharmacodynamic considerations in the development of therapeutic proteins (Q36097224) (← links)
- Dosage regimen design: pharmacodynamic considerations (Q36363552) (← links)
- Pharmacokinetic-pharmacodynamic modelling: history and perspectives (Q36365141) (← links)
- Population clinical pharmacology of children: modelling covariate effects. (Q36522932) (← links)
- Contributions of PK/PD modeling to intravenous anesthesia (Q37157264) (← links)
- Buprenorphine TTS for children – a review of the drug’s clinical pharmacology (Q37811033) (← links)
- Pharmacokinetics of non-intravenous formulations of fentanyl (Q38055713) (← links)
- Understanding the hysteresis loop conundrum in pharmacokinetic/pharmacodynamic relationships (Q38204833) (← links)
- Considerations when using pharmacokinetic/pharmacodynamic modeling to determine the effectiveness of simple analgesics in children. (Q38544082) (← links)
- Pharmacokinetic/pharmaco-dynamic modelling and simulation of the effects of different cannabinoid receptor type 1 antagonists on Δ(9)-tetrahydrocannabinol challenge tests (Q38937489) (← links)
- Fatal respiratory depression after multiple intravenous morphine injections (Q39344672) (← links)
- Onset of action of relaxants (Q39647815) (← links)
- Pharmacokinetics in Intravenous Anaesthetic Practice (Q40084501) (← links)
- Clinical pharmacokinetics of the non-depolarising muscle relaxants (Q40309335) (← links)
- Pharmacokinetic/pharmacodynamic modeling: what it is! (Q41310058) (← links)
- Neuromuscular Blockade: Offset Anomalies. Are they Simply Potency-related Receptor Bonding Effects? (Q41540975) (← links)
- Basic concepts in population modeling, simulation, and model-based drug development: part 3-introduction to pharmacodynamic modeling methods (Q41775229) (← links)
- Algorithms to rapidly achieve and maintain stable drug concentrations at the site of drug effect with a computer-controlled infusion pump (Q42108794) (← links)
- Increasing interest in PK and PD studies has many advantages for anesthesiologists (Q42255408) (← links)
- A pharmacokinetic-pharmacodynamic model for a muscle relaxant: atracurium (Q42640916) (← links)
- Assessing the utility of the utility function (Q42735892) (← links)
- Pharmacokinetic/pharmacodynamic relationships of transdermal buprenorphine and fentanyl in experimental human pain models. (Q42783945) (← links)
- Application of semilinear canonical correlation to the measurement of opioid drug effect (Q44330676) (← links)
- Relevance of frequent mu-opioid receptor polymorphisms for opioid activity in healthy volunteers (Q44351630) (← links)
- Competition between acetylcholine and a nondepolarizing muscle relaxant for binding to the postsynaptic receptors at the motor end plate: simulation of twitch strength and neuromuscular block (Q44474271) (← links)
- Effect compartment equilibration and time-to-peak effect. Importance of a pharmacokinetic-pharmacodynamic principle for the daily clinical practice (Q46565462) (← links)
- Comparison of some control strategies for three-compartment PK/PD models (Q46911567) (← links)
- Chemical substance kinetics in the case of chronobiological variations of elimination rate (Q46915935) (← links)
- A pharmacokinetic-pharmacodynamic model for neuromuscular blocking agents to predict train-of-four twitches (Q47662088) (← links)
- Anesthesia: a discipline that incorporates clinical pharmacology across the DDRU continuum (Q48489204) (← links)
- Estimating the rate of thiopental blood-brain equilibration using pseudo steady state serum concentrations (Q48954486) (← links)
- Pharmacodynamic modelling of the analgesic effects of piritramide in postoperative patients (Q51538206) (← links)
- Nocifensive reflex thresholds in rats: measures of central nervous system effects of barbiturates (Q51539885) (← links)
- A Normal Distribution Model for the Pharmacodynamics of Nondepolarizing Neuromuscular Blockers (Q51541469) (← links)
- Validation of a variable direction hysteresis minimization pharmacodynamic approach: cardiovascular effects of alfentanil (Q51644780) (← links)
- Pharmacokinetics and clinical anaesthesia (Q51827215) (← links)
- Accelerated onset of pancuronium with divided doses (Q51834655) (← links)
- Pharmacokinetic and pharmacodynamic modelling with pancuronium (Q51848757) (← links)
- Clinical pharmacokinetics of fazadinium (Q51874642) (← links)
- Pharmacokinetic-pharmacodynamic modeling of the miotic effects of dihydrocodeine in humans (Q51906646) (← links)